Jared Kaltwasser

The bill could have saved CMS about $26.5 billion had it been in place from 2018-2020, the study showed.

The exact reasons for the links are not yet clear, although some evidence suggests inflammation plays a role.

This new study examined uptake and use of a digital tool meant to aid in diabetes prevention.

The findings from among patients with myasthenia gravis (MG) could point the way to a potential new drug target, the authors said.

First steps include assembling equity data and reaching out to veterans’ advocacy groups.

The report also suggests that ataxia telangiectasia and Rad3-related protein inhibition could be a valuable tool to overcome resistance.

Patients were also more likely to stay in treatment longer when their care was delivered virtually, a new survey has found.

The report suggests that high-resolution micro-ultrasound could help identify clinically significant lesions that would be missed with conventional MRI.

This new study has found different labs followed similar practices, but the way they scored patients varied significantly.

A new review article shows how technologies like next-generation sequencing might help clinicians tailor care for myelodysplastic syndromes (MDS).

This experimental research suggests the expression levels of certain genes might help explain why people with lung cancer often have more severe cases of COVID-19.

Female patients and people younger than 18 years were particularly sensitive to pollution levels, this study found.

This new report shows people who used the digital therapeutic saw an improvement of 14% to 15% in their average blood glucose levels regardless of their racial or ethnic category.

The findings on tumor mutational burden (TMB) may fill a gap in biomarkers for patients who have non–small cell lung cancer (NSCLC).

The study authors said the method also has the advantages of having a quick turnaround and a relatively low cost.

The case is believed to be just the second reported in the scientific literature.

Patients who had non–small cell lung cancer (NSCLC) with homologous recombination gene mutations had better outcomes, although no single gene in the pathway appeared to have a causal role.

The findings include the identification of a 12-gene signature that could be used to categorize patients as high or low risk.

The new report found no evidence that second-generation tyrosine kinase inhibitors (TKIs) were more likely to lead to Clostridioides difficile infection (CDI) in patients with lung cancer.

Distal cholangiocarcinomas are rare, but clinicians can use a variety of imaging to diagnose it.

Although the skin condition is common in systemic lupus erythematosus (SLE), it usually is not the initial manifestation.

Aerobic capacity and cardiovascular risk both improve when people with systemic lupus erythematosus (SLE) exercise regularly, according to a new systematic review.

The study, based on care in Japan, found patients would be more quickly referred for targeted therapy.

Differences in overall survival between cannabis users and those who did not use the plant were small and could be explained by differences in the make-ups of the 2 cohorts of patients with non-small cell lung cancer, researchers said.

The data could help clinicians better identify patients who are good fits for belimumab after rituximab.

New research shows people with psychogenic nonepileptic seizures (PNES) have higher rates of childhood trauma of all types compared with people with epilepsy.

The study offers guidance to clinicians treating the roughly 10% of patients with rare EGFR mutations.

The new report is based on real-world data from a patient registry and shows some patients even regain motor function under treatment with nusinersen for spinal muscular atrophy (SMA).

The use of continuous glucose monitoring and attendance at a diabetes education appointment appeared to increase the odds of patient improvement.

The study of real-world evidence (RWE) found nearly 9 in 10 patients in a highly vaccinated cohort avoided hospitalization within 15 days of treatment for COVID-19.